Table 3.
Organ site | One-year PFS (%) | Pairwise log-rank test comparison to BoMs, p-value |
---|---|---|
Abdominal | 16.2% (8.6–25.8) | 0.40 |
Adrenal | 26.2% (19.0–33.9) | 0.03* |
Bone | 17.8% (13.6–22.4) | |
Brain | 26.3% (19.2–33.9) | 0.03* |
Liver | 15.7% (10.7–21.5) | 0.20 |
Lung | 30.2% (26.4–34.1) | <0.005* |
Lymph | 34.3% (30.0–38.7) | <0.005* |
*Indicates statistical significance, p<0.05.
PFS, progression free survival; BoMs, bone metastases.